CompletedNot Applicable

Physiotherapy Approach for Susac Syndrome

Bosnia and Herzegovina1 participantsStarted 2023-02-13

Plain-language summary

Susac's syndrome is a rare autoimmune disorder characterised by a triad of encephalopathy (brain dysfunction), branch retinal artery occlusion (loss of vision) and sensorineural hearing loss. This study presents the case of a patient undergoing intensive physiotherapy intervention following an injury, focusing on assessments such as volume and range of motion measurements, manual muscle tests, and pain intensity evaluations using various scales.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed diagnosis of Susac syndrome. * Willingness and ability to participate in a 12-week intensive physiotherapy program. * Stable medical condition that allows participation in physiotherapy without significant risks. * Ability to provide informed consent for participation in the study. Exclusion Criteria: * Presence of severe comorbidities or medical conditions that would interfere with participation in physiotherapy or confound the study outcomes. * Inability to comprehend or follow the instructions for physiotherapy exercises. * Pregnancy, as certain physiotherapy modalities may not be suitable during pregnancy. * Any other condition or circumstance that, in the opinion of the investigator, would compromise the safety or validity of participation in the study.

What they're measuring

Mobility and Muscle Strength Improvement

Timeframe: Assessed at baseline and after 12 weeks of intensive therapy.

Muscle Strength Improvement Outcome Measure

Timeframe: Assessed at baseline and after 12 weeks of intensive therapy.

Pain Intensity Outcome Measure

Timeframe: Assessed at baseline and after 12 weeks of intensive therapy.

Trial details

NCT IDNCT06349603

SponsorRehabilitation Centre Zivot

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-01

View on ClinicalTrials.gov More Susac Syndrome trials

Plain-language summary

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Mobility and Muscle Strength Improvement

Timeframe: Assessed at baseline and after 12 weeks of intensive therapy.

Muscle Strength Improvement Outcome Measure

Timeframe: Assessed at baseline and after 12 weeks of intensive therapy.

Pain Intensity Outcome Measure

Timeframe: Assessed at baseline and after 12 weeks of intensive therapy.